UnitedHealth Sinks 12% on CMS Fraud Rule as Warren Says Giants “Take a Cut at Every Step”

David Hanson • 4 minute read
Reviewed by: David Hanson
Last updated Nov 18, 2026

@photobyphotoboy via Canva, @NATEE MEEPIAN from Natee Meepian's Images via Canva

Key Takeaways

  • UnitedHealth fell 12% today on a proposed CMS anti-fraud rule, and Humana fell even more.
  • Sen. Elizabeth Warren has called for breaking up UnitedHealth, CVS Health and Cigna.
  • The rule is still a proposal, open for comment until Jan. 19, 2027.
  • The selloff looks overdone, but the look-back on past payments is the risk.

UnitedHealth Group (UNH) sank 12% today as investors sold health insurers for a second day over a proposed Medicare anti-fraud rule. Humana (HUM) fell even further.

Sen. Elizabeth Warren (D-Mass.) wrote on X that UnitedHealth, CVS Health (CVS) and Cigna (CI) “each own a health insurer, pharmacy middleman, and pharmacy” and “take a cut at every step.”

A rule that isn’t final yet

CMS’s proposed CRUSH rule would apply what auditors find in a sample of Medicare Advantage charts to a whole contract and claw back overpayments to payment year 2018.

Oppenheimer expects the rule to face the legal challenges that sank a similar framework in 2025. And even if it survives, “we believe plans would incorporate the prospective cost into bids rather than absorb an unchanged recurring earnings burden.”

Humana, down 12%, has the most riding on it: Medicare Advantage brought in $99.4 billion of its $129.7 billion of 2025 revenue.

CVS and Cigna take different hits

CVS fell 5%, and it’s exposed on both fronts. Aetna’s adjusted operating income rose to $912 million in the third quarter from $314 million a year earlier, mostly on its government business, which includes Medicare Advantage. That helped lift its 2026 adjusted EPS guide to at least $8.20.

Cigna fell 3%, though it sold its Medicare Advantage business in March 2025, so the audit rule barely reaches it. Warren’s post matters more: Evernorth, home to Express Scripts, brought in 86% of its third-quarter adjusted revenue.

TIKR tracks 26 analysts on UnitedHealth. How many say “Buy”?

See the full breakdown of Buy, Hold, and Sell ratings on UnitedHealth, along with Wall Street’s revenue and earnings estimates, all in one place. More than 500,000 investors use TIKR to research stocks like this one. See UnitedHealth’s Analyst Ratings

Overdone, with one catch

Analysts expected UnitedHealth’s normalized EPS to climb from $16.35 in 2025 to $27.04 by 2028:

Bar chart from TIKR of UnitedHealth Group's normalized EPS, actual and consensus estimates, $ per share, fiscal 2023-2028.
UnitedHealth Group (UNH): normalized EPS, actual and consensus estimates, $ per share, fiscal 2023-2028 (TIKR)

They predate the proposal, and Oppenheimer expects most recoveries in 2028-2030, putting 2028 most at risk.

UnitedHealth traded at 17x forward earnings at the last close, below its five-year average of 19x:

Line chart from TIKR of UnitedHealth Group's forward (NTM) P/E, last 5 years.
UnitedHealth Group (UNH): forward (NTM) P/E, last 5 years (TIKR)

At today’s price, it’s even lower.

The selloff has priced in a rule that’s open for comment until Jan. 19, 2027, and likely headed to court. The catch is the look-back to 2018, since no bid covers past years. Warren’s breakup push is a slower-moving risk.

UnitedHealth has promised its 2027 outlook before year-end. An adjusted EPS guide at or above the $23.33 consensus would signal little hit from CRUSH.

So what is UnitedHealth stock actually worth?

TIKR lets you forecast the future price of any stock in less than a minute. Just enter a few assumptions into TIKR’s valuation model and see what UnitedHealth could be worth. Start from Wall Street consensus estimates, or adjust the inputs to reflect your own view of the business. It’s free to use.

Value UnitedHealth for free

Disclaimer:

Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any of the stocks mentioned. Thank you for reading, and happy investing!

Join thousands of investors worldwide who use TIKR to supercharge their investment analysis.

Sign Up for FREENo credit card required